Overexpression of a constitutively active (CA) mutant of RhoA in GBM TICs restores their mechanosensitivity to ECM stiffness, retards cell motility on soft ECMs by increasing myosin-dependent cell contractility, and suppresses tumor invasion in vivo [144]. The gene discussed is RHOA; the disease is neoplasm.